Cyanobacteria and cyanometabolites used in the pharmaceutical and medical industry

• Authors: Sylwia Śliwińska-Wilczewska
• Languages of publication: EN

Abstracts

EN

Związki bioaktywne sinic wykazują różnorodne właściwości, które potencjalnie mogą być wykorzystane w wielu sektorach przemysłu. W artykule tym szczególny nacisk położono na wykorzystanie sinic i ich cyjanometabolitów, zarówno w przemyśle farmaceutycznym, jak i medycznym. Scharakteryzowano związki wyizolowane ze szczepów sinic, które można stosować do wytwarzania leków o działaniu przeciwwirusowym, przeciwgrzybiczym, przeciwnowotworowym, przeciwdrobnoustrojowym oraz przeciwbakteryjnym. Pokazano również pozytywne aspekty hodowli sinic i możliwości ich komercyjnego wykorzystania.

Keywords

EN

applications; blue-green algae; cyanobacteria; cyanometabolites; industry

• Publisher: Uniwersytet Komisji Edukacji Narodowej w Krakowie
• Journal: Annales Universitatis Paedagogicae Cracoviensis Studia Naturae
• Year: 2019
• Pages: 180-190

Dates

published

2019-12-31

Contributors

author

Sylwia Śliwińska-Wilczewska

• Institute of Oceanography, University of Gdansk, Av. Piłsudskiego 46, 81-378 Gdynia, Poland

References

• AlgaeBase https://www.algaebase.org/. 1996–2019 M.D. Guiry.
• Almeida, J., Freitas, M., Cruz, S., Leão, P., Vasconcelos, V., Cunha, I. (2015). Acetylcholinesterase in biofouling species: characterization and mode of action of cyanobacteria-derived antifouling agents. Toxins, 7, 2739–2756. https://doi.org/10.3390/toxins7082739
• Berry, J.P., Gantar, M., Perez, M.H., Berry, G., Noriega, F.G. (2008). Cyanobacterial toxins as allelochemicals with potential applications as algaecides, herbicides and insecticides. Marine Drugs, 15, 117–146. https://doi.org/10.3390/md20080007
• Blom, J.F., Brütsch, T., Barbaras, D., Bethuel, Y., Locher, H.H., Hubschwerlen, C., Gademann, K. (2006). Potent algicides based on the cyanobacterial alkaloid nostocarboline. Organic Letters, 8(4), 737–740. https://doi.org/10.1021/ol052968b
• Bokesch, H.R., O'Keefe, B.R., McKee, T.C., Pannell, L.K., Patterson, G.M., Gardella, R.S., Boyd, M.R. (2003). A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema varium. Biochemistry, 42(9), 2578–2584. https://doi.org/10.1021/bi0205698
• Burja, A.M., Banaigs, B., Abou-Mansour, E., Burgess, J.G., Wright, P.C. (2001). Marine cyanobacteria – a prolific source of natural products. Tetrahedron, 57(46), 9347–9377. https://doi.org/10.1016/S0040-4020(01)00931-0
• Costa, M., Costa-Rodrigues, J., Fernandes, M.H., Barros, P., Vasconcelos, V., Martins, R. (2012). Marine cyanobacteria compounds with anticancer properties: A review on the implication of apoptosis. Marine Drugs, 10(10), 2181–2207. https://doi.org/10.3390/md10102181
• Costa, M., Garcia, M., Costa-Rodrigues, J., Costa, M.S., Ribeiro, M.J., Fernandes, M.H., Martins, R. (2014). Exploring bioactive properties of marine cyanobacteria isolated from the Portuguese Coast: High potential as a source of anticancer compounds. Marine Drugs, 12, 98–114. https://doi.org/10.3390/md12010098
• El-Baky, H.H.A. (2003). Over production of phycocyanin pigment in blue green alga Spirulina sp. and it’s inhibitory effect on growth of Ehrlich ascites carcinoma cells. Journal of Medical Science, 3(4), 314–324. https://doi.org/10.3923/jms.2003.314.324
• Falch, B.S., König, G.M., Wright, A.D., Sticher, O., Angerhofer, C.K., Pezzuto, J.M., Bachmann, H. (1995). Biological activities of cyanobacteria: evaluation of extracts and pure compounds. Planta Medica, 61(04), 321–328. https://doi.org/10.1055/s-2006-958092
• Garima, A.C., Goyal, P., Kaushik, P. (2013). Antibacterial and anticandidal screening of extracellular and intracellular extracts of Phormedium, a Cyanobacterium. International Journal of Chemical and Life Sciences, 2, 1107–1111.
• Głowacka, J., Waleron, M., Szefel-Markowska, M., Łojkowska, E., Waleron, K. (2007). Cyanobacteria – source of biologically active compounds. Biotechnologia, 4(79), 95–112. [In Polish]
• Gupta, V., Ratha, S.K., Sood, A., Chaudhary, V., Prasanna, R. (2013). New insights into the biodiversity and applications of cyanobacteria (blue-green algae) – prospects and challenges. Algal Research, 2(2), 79–97. https://doi.org/10.1016/j.algal.2013.01.006
• Gustafson, K.R., Cardellina, J.H., Fuller, R.W., Weislow, O.S., Kiser, R.F., Snader, K.M., Patterson, G.M.L., Boyd, M.R. (1989). AIDS-antiviral sulfolipids from cyanobacteria (blue-green algae). JNCI: Journal of the National Cancer Institute, 81(16), 1254–1258.
• Gutiérrez, M., Suyama, T.L., Engene, N., Wingerd, J.S., Matainaho, T., Gerwick, W.H. (2008). Apratoxin D, a potent cytotoxic cyclodepsipeptide from Papua New Guinea collections of the marine cyanobacteria Lyngbya majuscula and Lyngbya sordida. Journal of Natural Products, 71(6), 1099–1103. https://doi.org/10.1021/np800121a
• Hagmann, L., Jüttner, F. (1996). Fischerellin A, a novel photosystem-II-inhibiting allelochemical of the cyanobacterium Fischerella muscicola with antifungal and herbicidal activity. Tetrahedron Letters, 37(36), 6539–6542. https://doi.org/10.1016/0040-4039(96)01445-1
• Harada, K.I., Suomalainen, M., Uchida, H., Masui, H., Ohmura, K., Kiviranta, J., Niku-Paavola, M.L., Ikemoto, T. (2000). Insecticidal compounds against mosquito larvae from Oscillatoria agardhii strain 27. Environmental Toxicology: An International Journal, 15(2), 114–119. https://doi.org/10.1002(SICI)1522-7278(2000)15:23.0.CO;2-P
• Imhoff, J.F., Labes A., Wiese, J. (2011). Bio-mining the microbial treasures of the ocean: new natural products. Biotechnology Advances, 29, 468–482. https://doi.org/10.1016/j.biotechadv.2011.03.001
• Ishida, K., Nakagawa, H., Murakami, M. (2000). Microcyclamide, a cytotoxic cyclic hexapeptide from the cyanobacterium Microcystis aeruginosa. Journal of Natural Products, 63(9), 1315–1317. https://doi.org/10.1021/np000159p
• Ishimi, Y., Sugiyama, F., Ezaki, J., Fujioka, M., Wu, J. (2006). Effects of Spirulina, a blue-green alga, on bone metabolism in ovariectomized rats and hindlimb-unloaded mice. Bioscience, Biotechnology, and Biochemistry, 70(2), 363–368. https://doi.org/10.1271/bbb.70.363
• Kalemkerian, G.P., Ou, X., Adil, M.R., Rosati, R., Khoulani, M.M., Madan, S.K., Pettit, G.R. (1999). Activity of dolastatin 10 against small-cell lung cancer in vitro and in vivo: induction of apoptosis and bcl-2 modification. Cancer Chemotherapy and Pharmacology, 43(6), 507–515. https://doi.org/10.1007/s002800050931
• Kim, J.D. (2006). Screening of cyanobacteria (blue-green algae) from rice paddy soil for antifungal activity against plant pathogenic fungi. Mycobiology, 34(3), 138–142. https://doi.org/10.4489/MYCO.2006.34.3.138
• Klasik, S., Zych, M., Kaczmarczyk-Sedlak, I. (2010). Cyanobacteria (Cyanophyta)–classification, structure of the cell and significance; Spirulina platensis and her therapeutic significance for the human’s body. Medycyna Rodzinna, 4, 120–123.
• Kreitlow, S., Mundt, S., Lindequist, U. (1999). Cyanobacteria – a potential source of new biologically active substances. Journal of Biotechnology, 70(1–3), 61–63. https://doi.org/10.1016/S0168-1656(99)00058-9
• Lam, K.S. (2007). New aspects of natural products in drug discovery. Trends in Microbiology, 15(6), 279–289. https://doi.org/10.1016/j.tim.2007.04.001
• Larsen, L.K., Moore, R.E., Patterson, G.M. (1994). β-Carbolines from the blue-green alga Dichothrix baueriana. Journal of Natural Products, 57(3), 419–421. https://doi.org/10.1021/np50105a018
• Lau, A.F., Siedlecki, J., Anleitner, J., Patterson, G.M., Caplan, F.R., Moore, R.E. (1993). Inhibition of reverse transcriptase activity by extracts of cultured blue-green algae (Cyanophyta). Planta Medica, 59(2), 148–151. https://doi.org/10.1055/s-2006-959631
• Leão P.N., Engene, N., Antunes, A., Gerwick, W.H., Vasconcelos, V. (2012). The chemical ecology of cyanobacteria. Natural Product Reports, 29, 372–391. https://doi.org/10.1039/c2np00075j
• Linington, R.G., Edwards, D.J., Shuman, C.F., McPhail, K.L., Matainaho, T., Gerwick, W.H. (2008). Symplocamide A, a potent cytotoxin and chymotrypsin inhibitor from the marine cyanobacterium Symploca sp. Journal of Natural Products, 71(1), 22–27. https://doi.org/10.1021/np070280x
• Liu, Y., Law, B.K., Luesch, H. (2009). Apratoxin a reversibly inhibits the secretory pathway by preventing cotranslational translocation. Molecular Pharmacology, 76(1), 91–104. https://doi.org/10.1124/mol.109.056085
• Łukomska, J., Kasprzykowski, F., Łankiewicz, L., Grzonka, Z. (2002). Peptide toxins from cyanobacteria. Wiadomości Chemiczne, 56(1–2), 57–82. [In Polish]
• Mazur-Marzec, H., Błaszczyk, A., Felczykowska, A., Hohlfeld, N., Kobos, J., Toruńska-Sitarz, A., Devi, P., Montalvão, S., D’souza, L., Tammela, P., Mikosik, A., Bloch, S., Nejman-Faleńczyk, B., Węgrzyn, G. (2015). Baltic cyanobacteria–a source of biologically active compounds. European Journal of Phycology, 50, 343–360. https://doi.org/10.1080/09670262.2015.1062563
• Nuhu, A.A. (2013). Spirulina (Arthrospira): An important source of nutritional and medicinal compounds. Journal of Marine Biology, ID 325636. https://doi.org/10.1155/2013/325636
• Oufdou, K., Mezrioui, N., Oudra, B., Loudiki, M., Barakate, M., Sbiyyaa, B. (2001). Bioactive compounds from Pseudanabaena species (Cyanobacteria). Microbios, 106, 21–29.
• Patterson, G.M.L., Bolis, C.M. (1995). Regulation of scytophycin accumulation in cultures of Scytonema ocellatum. II. Nutrient requirements. Applied Microbiology and Biotechnology, 43(4), 692–700. https://doi.org/10.1007/BF00164775
• Rao, D.R., Thangavel, C., Kabilan, L., Suguna, S., Mani, T.R., Shanmugasundaram, S. (1999). Larvicidal properties of the cyanobacterium Westiellopsis sp. (blue-green algae) against mosquito vectors. Transactions of the Royal Society of Tropical Medicine and Hygiene, 93(3), 232–232. https://doi.org/10.1016/S0035-9203(99)90002-0
• Rickards, R.W., Rothschild, J.M., Willis, A.C., de Chazal, N.M., Kirk, J., Kirk, K., Smith, G.D. (1999). Calothrixins A and B, novel pentacyclic metabolites from Calothrix cyanobacteria with potent activity against malaria parasites and human cancer cells. Tetrahedron, 55(47), 13513–13520. https://doi.org/10.1016/S0040-4020(99)00833-9
• Rubio, B.K., Parrish, S.M., Yoshida, W., Schupp, P.J., Schils, T., Williams, P.G. (2010). Depsipeptides from a Guamanian marine cyanobacterium, Lyngbya bouillonii, with selective inhibition of serine proteases. Tetrahedron Letters, 51(51), 6718–6721.
• Sheih, I.C., Fang, T.J., Wu, T.K., Lin, P.H. (2009). Anticancer and antioxidant activities of the peptide fraction from algae protein waste. Journal of Agricultural and Food Chemistry, 58(2), 1202–1207. https://doi.org/10.1021/jf903089m
• Shih, C., Teicher, B.A. (2001). Cryptophycins: a novel class of potent antimitotic antitumor depsipeptides. Current Pharmaceutical Design, 7(13), 1259–1276. https://doi.org/10.2174/1381612013397474
• Simmons, T.L., Andrianasolo, E., McPhail, K., Flatt, P., Gerwick, W.H. (2005). Marine natural products as anticancer drugs. Molecular Cancer Therapeutics, 4(2), 333–342.
• Simmons, T.L., Engene, N., Ureña, L.D., Romero, L.I., Ortega-Barría, E., Gerwick, L., Gerwick, W.H. (2008). Viridamides A and B, lipodepsipeptides with antiprotozoal activity from the marine cyanobacterium Oscillatoria nigro-viridis. Journal of Natural Products, 71(9), 1544–1550. https://doi.org/10.1021/np800110e
• Singh, R.K., Tiwari, S.P., Rai, A.K., Mohapatra, T.M. (2011). Cyanobacteria: an emerging source for drug discovery. The Journal of Antibiotics, 64(6), 401. https://doi.org/10.1038/ja.2011.21
• Srivastava, A., Jüttner, F., Strasser, R.J. (1998). Action of the allelochemical, fischerellin A, on photosystem II. Biochimica et Biophysica Acta (BBA)-Bioenergetics, 1364(3), 326–336. https://doi.org/10.1016/S0005-2728(98)00014-0
• Vijayakumar, S., Menakha, M. (2015). Pharmaceutical applications of cyanobacteria – A review. Journal of Acute Medicine, 5(1), 15–23. https://doi.org/10.1016/j.jacme.2015.02.004
• Wall, N.R., Mohammad, R.M., Al-Katib, A.M. (1999). Bax: Bcl-2 ratio modulation by bryostatin 1 and novel antitubulin agents is important for susceptibility to drug induced apoptosis in the human early pre-B acute lymphoblastic leukemia cell line, Reh. Leukemia Research, 23(10), 881–888. https://doi.org/10.1016/s0145-2126(99)00108-3
• Wright, A.D., Papendorf, O., König, G.M. (2005). Ambigol C and 2, 4-Dichlorobenzoic Acid, Natural Products Produced by the Terrestrial Cyanobacterium Fischerella ambigua. Journal of Natural Products, 68(3), 459–461. https://doi.org/10.1021/np049640w
• Yasuhara-Bell, J., Lu, Y. (2010). Marine compounds and their antiviral activities. Antiviral Research, 86(3), 231–240. https://doi.org/10.1016/j.antiviral.2010.03.009
• Zainuddin, E., Mundt, S., Wegner, U., Mentel, R. (2002). Cyanobacteria a potential source of antiviral substances against influenza virus. Medical Microbiology and Immunology, 191(3–4), 181–182. https://doi.org/10.1007/s00430-002-0142-1

Identifiers

DOI

10.24917/25438832.4.12